A Phase 2 study found a placebo-adjusted reduction of 5.3 moderate-to-severe hot flashes per day at week four. AbCellera listed more than $890 million in available liquidity as of Sept. 30.
Discover more from Coin Gazette
Subscribe to get the latest posts sent to your email.
